Premier Pharma E LP
Premier Pharma E LP is a private investment fund based in New York. Its most recent Form D, filed Dec 7, 2016, reports no sales yet. The minimum investment it accepts from an outside investor is $50,000. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Jeremy Beal; Morgan Stanley Strategies II LLC; James Bruno.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- $50,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Jeremy Beal; Morgan Stanley Strategies II LLC; James Bruno
- Latest Form D
- Dec 7, 2016
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Premier Pharma E LP
What is the minimum investment for Premier Pharma E LP?
According to its latest Form D, filed Dec 7, 2016, the minimum investment Premier Pharma E LP accepts from an outside investor is $50,000.
Who can invest in Premier Pharma E LP?
Premier Pharma E LP is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.
How much has Premier Pharma E LP raised?
Premier Pharma E LP's latest Form D, filed Dec 7, 2016, reports no sales yet.
Where is Premier Pharma E LP based?
Premier Pharma E LP is based in New York.
Size compared with every private investment fund
This fund hasn't reported any sales yet.